Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yury Popov

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Gastroenterology|June 10, 2008
Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progressionEleonora Patsenker, Yury Popov, Felix Stickel, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 13, 2012
Tissue-specific differences in inflammatory infiltrate and matrix metalloproteinase expression in adipose tissue and liver of mice with diet-induced obesityVincent E de Meijer, Deanna Y Sverdlov, Hau D Le, et al.
Hepatology (Baltimore, Md.)|October 27, 2005
Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the ratDaniel Benten, Vinay Kumaran, Brigid Joseph, et al.
Gastroenterology|July 14, 2005
Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cellsAnja Schulze-Krebs, Dorothee Preimel, Yury Popov, et al.
Plos One|October 8, 2011
Tumor necrosis factor α-converting enzyme inhibition reverses hepatic steatosis and improves insulin sensitivity markers and surgical outcome in miceVincent E de Meijer, Hau D Le, Jonathan A Meisel, et al.
Hepatology (Baltimore, Md.)|June 23, 2015
Specific hepatic delivery of procollagen α1(I) small interfering RNA in lipid-like nanoparticles resolves liver fibrosisCarolina Jiménez Calvente, Alfica Sehgal, Yury Popov, et al.
Hepatology (Baltimore, Md.)|September 3, 2009
Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesisEleonora Patsenker, Yury Popov, Felix Stickel, et al.
Journal of Hepatology|January 29, 2008
Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapiesYury Popov, Eleonora Patsenker, Felix Stickel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 25, 2015
Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in miceSusan B Liu, Naoki Ikenaga, Zhen-Wei Peng, et al.
The American Journal of Pathology|December 6, 2014
A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancerNaoki Ikenaga, Susan B Liu, Deanna Y Sverdlov, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Gastroenterology|June 10, 2008
Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progressionEleonora Patsenker, Yury Popov, Felix Stickel, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 13, 2012
Tissue-specific differences in inflammatory infiltrate and matrix metalloproteinase expression in adipose tissue and liver of mice with diet-induced obesityVincent E de Meijer, Deanna Y Sverdlov, Hau D Le, et al.
Hepatology (Baltimore, Md.)|October 27, 2005
Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the ratDaniel Benten, Vinay Kumaran, Brigid Joseph, et al.
Gastroenterology|July 14, 2005
Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cellsAnja Schulze-Krebs, Dorothee Preimel, Yury Popov, et al.
Plos One|October 8, 2011
Tumor necrosis factor α-converting enzyme inhibition reverses hepatic steatosis and improves insulin sensitivity markers and surgical outcome in miceVincent E de Meijer, Hau D Le, Jonathan A Meisel, et al.
Hepatology (Baltimore, Md.)|June 23, 2015
Specific hepatic delivery of procollagen α1(I) small interfering RNA in lipid-like nanoparticles resolves liver fibrosisCarolina Jiménez Calvente, Alfica Sehgal, Yury Popov, et al.
Hepatology (Baltimore, Md.)|September 3, 2009
Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesisEleonora Patsenker, Yury Popov, Felix Stickel, et al.
Journal of Hepatology|January 29, 2008
Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapiesYury Popov, Eleonora Patsenker, Felix Stickel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 25, 2015
Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in miceSusan B Liu, Naoki Ikenaga, Zhen-Wei Peng, et al.
The American Journal of Pathology|December 6, 2014
A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancerNaoki Ikenaga, Susan B Liu, Deanna Y Sverdlov, et al.
Pageof 4